CD24HICD38HI TRANSITIONAL B CELLS AND CD9 AS NEW BIOMARKER OF LONG-TERM HUMAN LUNG ALLOGRAFT SURVIVAL

The present invention relates to an in vitro method for determining the risk of occurrence of chronic lung graft dysfunction in a human subject comprising: a) measuring the level of CD9 + B cells in a blood sample of the subject, b) comparing the level of CD9 + B cells measured at step a) with one o...

Full description

Saved in:
Bibliographic Details
Main Authors DURAND, Maxim, BROSSEAU, Carole, MAGNAN, Antoine, BROUARD, Sophie
Format Patent
LanguageEnglish
French
German
Published 04.03.2020
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an in vitro method for determining the risk of occurrence of chronic lung graft dysfunction in a human subject comprising: a) measuring the level of CD9 + B cells in a blood sample of the subject, b) comparing the level of CD9 + B cells measured at step a) with one or more reference values of the level of CD9 + B cells, and c) determining the risk of occurrence of chronic lung graft dysfunction in the said subject from the comparison performed at step b).
Bibliography:Application Number: EP20180718862